Kaiser Permanente Research
Kaiser regions include Colorado, Georgia, Hawaii, Mid-Atlantic States (VA, MD, DC), Northern California, Northwest (Oregon/Washington) and Southern California. Each Kaiser Permanente region has its own research enterprise. Each regional research enterprise has its own leadership and areas of emphasis. Kaiser Permanente research is primarily funded by such external sources as the National Institutes for Health and the Centers for Disease Control, and it reaches beyond clinical practice to include behavioral, genetic, and environmental research. The research enterprises encourage collaboration among themselves, and many projects are interregional. For such projects, each region will likely have its own investigator to facilitate the research and ensure quality results.
Further, the Kaiser Foundation Research Institute, which holds the FWA for Kaiser Permanente, develops and assures compliance with research-related government regulations and Kaiser Permanente policies and procedures. Kaiser Foundation Research Institute also works with the Kaiser Permanente National Research Council (here represented by Drs. Horberg and Jacobsen, along with Director of Kaiser Foundation Research Institute Dr. Emmons) to develop and implement the Kaiser Permanente Research strategy. All Kaiser Permanente regions participate in the PCORnet PORTAL CDRN. The RCC will work to promote the Kaiser Permanente/Johns Hopkins collaboration broadly in Kaiser Permanente.
Mid-Atlantic Permanente Research Institute (MAPRI)
MAPRI is the research enterprise for Kaiser Permanente Mid-Atlantic States region, within the Mid-Atlantic Permanente Medical Group (MAPMG), with the mission to advance medical knowledge and improve the quality of care and health of our patients and communities we serve by conducting innovative scientific and clinical research. MAPRI staff encompass a wide range of expertise, including clinical trials, health services and health policy research, epidemiology, health informatics, biostatistics, data management, research grants and contract administration, and numerous clinical specialties.
MAPRI research staff have full access to KPMAS databases, registries, and data with appropriate IRB approval. Close ties with the Medical Group and Health Plan enable a number of support services, including comprehensive health education departments and libraries, an extensive regionalized data management system, and communications team. In addition, collaborative ties exist with various local institutions, as well as other organizations across the U.S., including other Kaiser Permanente research units and the HMO Research Network (HMORN), the NIAID-sponsored North American HIV Observational Cohort Collaboration (NA-ACCORD), Cancer Research Network (CRN), and the FDA Mini-Sentinel Initiative.
Johns Hopkins Research
Johns Hopkins Medicine (School of Medicine and Johns Hopkins Health System) and the broader Johns Hopkins University have a comprehensive research program spanning basic to clinical to population and health services research. All of this research is administered through the Johns Hopkins University. Johns Hopkins University is the number one recipient of NIH funding and has seen a significant increase in commercially funded clinical research as well.
The Johns Hopkins School of Medicine had $715 million dollars of sponsored research in the year that ended on June 30, 2015. There are over 7,500 active clinical protocols with about 1,400 active clinical trials. The Johns Hopkins Medicine’s research mission includes child, older adults, cancer, infectious diseases, HIV, and addictions. Johns Hopkins has active research programs in quality improvement in both hospital and ambulatory settings. It supports clinical trials in all of our hospitals. Johns Hopkins has a CTSA grant (Institute for Clinical and Translational Research) and is a member of the PCORnet PATH CDRN.